NCT05796635 is a NA clinical trial of Herpecin L in Cold Sores, sponsored by Focus Consumer Healthcare.

Who is sponsoring NCT05796635?

NCT05796635 is sponsored by Focus Consumer Healthcare.

What drugs are being tested in NCT05796635?

Interventions in NCT05796635: Herpecin L.

What condition does NCT05796635 study?

NCT05796635 studies Cold Sores.

Is NCT05796635 still recruiting?

NCT05796635 is currently completed. Last updated 3 April 2023.

Last reviewed 2023-04-03 · How we verify

NCT05796635

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores

Completed NA Last updated 3 April 2023

What this trial tests

NA trial testing Herpecin L in Cold Sores in 80 participants. Completed in 20 February 2023.

Timeline

4 January 2023

Primary endpoint
26 January 2023

20 February 2023

Quick facts

Lead sponsor	Focus Consumer Healthcare
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	80
Start date	4 January 2023
Primary completion	26 January 2023
Estimated completion	20 February 2023
Sites	1 location across United States

Drugs / interventions tested

Herpecin L

Conditions studied

Cold Sores — all drugs for Cold Sores →

Sponsor

Focus Consumer Healthcare

Who can join

Adults 18 to 60, any sex, with Cold Sores. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Focus Consumer Healthcare has developed Herpecin L. Herpecin L combines many different ingredients hypothesized to promote quick healing and symptom reduction from cold sores.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Focus Consumer Healthcare trials

Trials by the same sponsor.

NCT05845970 — An Investigation Into the Efficacy of a Botanical Supplement to Provide Period Relief · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05796635 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Focus Consumer Healthcare
Last refreshed: 3 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05796635.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing